{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36961855",
  "DateCompleted": {
    "Year": "2023",
    "Month": "03",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "04",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "03",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0283576",
      "10.1371/journal.pone.0283576"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "3",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges.",
    "Pagination": {
      "StartPage": "e0283576",
      "MedlinePgn": "e0283576"
    },
    "Abstract": {
      "AbstractText": [
        "COVID-19 oral treatments require initiation within 5 days of symptom onset. Although antigen tests are less sensitive than RT-PCR, rapid results could facilitate entry to treatment. We collected anterior nasal swabs for BinaxNOW and RT-PCR testing and clinical data at a walk-up, community site in San Francisco, California between January and June 2022. SARS-CoV-2 genomic sequences were generated from positive samples and classified according to subtype and variant. Monte Carlo simulations were conducted to estimate the expected proportion of SARS-CoV-2 infected persons who would have been diagnosed within 5 days of symptom onset using RT-PCR versus BinaxNOW testing. Among 25,309 persons tested with BinaxNOW, 2,799 had concomitant RT-PCR. 1137/2799 (40.6%) were SARS-CoV-2 RT-PCR positive. We identified waves of predominant omicron BA.1, BA.2, BA.2.12, BA.4, and BA.5 among 720 sequenced samples. Among 1,137 RT-PCR positive samples, 788/1137 (69%) were detected by BinaxNOW; 94% (669/711) of those with Ct value <30 were detected by BinaxNOW. BinaxNOW detection was consistent over lineages. In analyses to evaluate entry to treatment, BinaxNOW detected 81.7% (361/442, 95% CI: 77-85%) of persons with COVID-19 within 5 days of symptom onset. In comparison, RT-PCR (24-hour turnaround) detected 84.2% (372/442, 95% CI: 80-87%) and RT-PCR (48-hour turnaround) detected 67.0% (296/442, 95% CI: 62-71%) of persons with COVID-19 within 5 days of symptom onset. BinaxNOW detected high viral load from anterior nasal swabs consistently across omicron sublineages emerging between January and June of 2022. Simulations support BinaxNOW as an entry point for COVID-19 treatment in a community field setting."
      ],
      "CopyrightInformation": "Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Schrom",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Marquez",
        "ForeName": "Carina",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Chung-Yu",
        "Initials": "CY"
      },
      {
        "Identifier": [
          "0000-0001-5736-5180"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Saxena",
        "ForeName": "Aditi",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Mitchell",
        "ForeName": "Anthea M",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Ribeiro",
        "ForeName": "Salu",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Pilarowski",
        "ForeName": "Genay",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "California Department of Public Health, Richmond, California, United States of America."
          }
        ],
        "LastName": "Nakamura",
        "ForeName": "Robert",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Rojas",
        "ForeName": "Susana",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Black",
        "ForeName": "Douglas",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Contreras Oseguera",
        "ForeName": "Maria G",
        "Initials": "MG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Diaz",
        "ForeName": "Edgar Castellanos",
        "Initials": "EC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Payan",
        "ForeName": "Joselin",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Rojas",
        "ForeName": "Susy",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Jones",
        "ForeName": "Diane",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud and Latino Task Force, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Tulier-Laiwa",
        "ForeName": "Valerie",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud and Latino Task Force, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Zavaleta",
        "ForeName": "Aleks",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidos en Salud, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Martinez",
        "ForeName": "Jacqueline",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Chamie",
        "ForeName": "Gabriel",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "California Department of Public Health, Richmond, California, United States of America."
          }
        ],
        "LastName": "Glaser",
        "ForeName": "Carol",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "California Department of Public Health, Richmond, California, United States of America."
          }
        ],
        "LastName": "Jacobson",
        "ForeName": "Kathy",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Biostatistics, University of California, Berkeley, Berkeley, California, United States of America."
          }
        ],
        "LastName": "Petersen",
        "ForeName": "Maya",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chan Zuckerberg Biohub, San Francisco, California, United States of America."
          }
        ],
        "LastName": "DeRisi",
        "ForeName": "Joseph",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0003-0761-3136"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, United States of America."
          }
        ],
        "LastName": "Havlir",
        "ForeName": "Diane V",
        "Initials": "DV"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "San Francisco"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunologic Tests"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}